NCT03306641 is a NA clinical trial of Test Contact Lens in Myopia, sponsored by CooperVision, Inc..

Who is sponsoring NCT03306641?

NCT03306641 is sponsored by CooperVision, Inc..

What drugs are being tested in NCT03306641?

Interventions in NCT03306641: Test Contact Lens, Nelfilcon A.

Is NCT03306641 still recruiting?

NCT03306641 is currently completed. Last updated 22 September 2020.

Are results published for NCT03306641?

Yes — primary outcome results have been posted to ClinicalTrials.gov. See the outcomes section above for details.

Last reviewed 2020-09-22 · How we verify

NCT03306641

Name: Drug Landscape Pharmaceutical Database
Creator: Drug Landscape
Published: 2026-01-01
License: https://creativecommons.org/licenses/by/4.0/

A One-Week Crossover Dispensing Evaluation of New Daily Wear Soft Contact Lenses

Completed NA Results posted Last updated 22 September 2020

What this trial tests

NA trial testing Test Contact Lens in Myopia in 45 participants. Completed in 31 August 2017.

Timeline

28 July 2017

Primary endpoint
31 August 2017

31 August 2017

Quick facts

Lead sponsor	CooperVision, Inc.
Phase	NA
Status	Completed
Study type	INTERVENTIONAL
Allocation	randomized
Design	crossover
Masking	double
Primary purpose	treatment
Enrollment	45
Start date	28 July 2017
Primary completion	31 August 2017
Estimated completion	31 August 2017
Sites	1 location across United States

Drugs / interventions tested

Test Contact Lens
Nelfilcon A — full drug profile →

Conditions studied

Myopia — all drugs for Myopia →

Sponsor

CooperVision, Inc.

Who can join

Adults 18 to 55, any sex, with Myopia. Patients with the condition only — healthy volunteers not accepted.

Results — posted to ClinicalTrials.gov

Per-arm endpoint measurements with 95% confidence intervals where reported. Source: trial results section.

Lens Fit Acceptance Primary · Baseline

Overall lens fit acceptance was measured on a scale of 0-4 in 0.25 steps (0=can't be worn, 1=Poor, 2=Fair, 3=Good, 4=Optimum)

Group	Value	95% CI
Test Contact Lens	2.6	± 0.6
Nelfilcon A Lens (Control)	3.1	± 0.3

Lens Fit Acceptance Primary · 1-Week

Overall lens fit acceptance was measured on a scale of 0-4 in 0.25 steps (0=can't be worn, 1=Poor, 2=Fair, 3=Good, 4=Optimum)

Group	Value	95% CI
Test Contact Lens	2.6	± 0.6
Nelfilcon A Lens (Control)	3.0	± 0.4

Sponsor's own description

The purpose of this study is to validate the clinical performance of a new contact lens design when worn over a period 1 week compared to nelfilcon A (control).

Publications & conference data

No peer-reviewed publications indexed yet for this trial. Completed trials usually publish results within 12-18 months.

Verify or expand the search:

Other trials of Test Contact Lens

Trials testing the same drug.

NCT04492397 — Comparing The Performance Of Two Different Daily Disposable Lenses (MIKI) · NA · completed
NCT02699593 — Clinical Evaluation of Approved Contact Lenses · NA · completed

Other recruiting trials for Myopia

Currently open trials in the same condition.

NCT07284966 — Comfort and Vision With TOTAL30 Multifocal Lenses · recruiting
NCT07078799 — Wavefront-guided LASIK Surgery Compared to Ray Tracing-Guided LASIK Surgery · NA · recruiting
NCT07585877 — Effect of Branched-Chain Amino Acid Supplementation on Myopia Progression · NA · active not recruiting
NCT07354945 — An Evaluation of Myopia Control Lenses on Wearing Experience in Myopic Children · NA · recruiting
NCT07229365 — Children's Viewing Behavior · NA · recruiting

Other CooperVision, Inc. trials

Trials by the same sponsor.

NCT06817785 — Soft Lens Study: Biomedics 1 Day Extra Sphere and Clariti 1 Day Sphere · NA · completed
NCT06758076 — A Clinical Comparison of Two Soft Contact Lenses (C24-755) · NA · completed
NCT06590441 — Investigation of Wearing Compliance of Spectacles for Myopia Control · completed
NCT06609018 — Clinical Investigation of Buttermere (LENS 271) Soft Contact Lenses · NA · completed
NCT06611410 — 1 Week Crossover Study Between Two Soft Contact Lenses · NA · completed

Verify against primary sources

ClinicalTrials.gov — authoritative US registry record
WHO ICTRP — international registry index
EU Clinical Trials Register
Sponsor press releases (Google)

Data sources for this page

Trial protocol + status: ClinicalTrials.gov NCT03306641 (US National Library of Medicine, public domain)
Drug + disease cross-links: matched in real time against Drug Landscape's normalised drug + company + condition tables
Sponsor: as reported to ClinicalTrials.gov by CooperVision, Inc.
Last refreshed: 22 September 2020

Drug Landscape aggregates and links these public records for informational use only. Always verify against the primary source before clinical or regulatory decisions. Canonical URL: https://druglandscape.com/trial/NCT03306641.

Primary sources · FDA · ClinicalTrials.gov · EMA · SEC EDGAR · ChEMBL · Wikidata · full sourcing